Status:

COMPLETED

The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease

Lead Sponsor:

University of Colorado, Denver

Conditions:

Bladder Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The investigators hypothesize that circulating tumor cells (CTC) will be observed in patients with muscle-invasive or metastatic bladder cancer and that CTC will become undetectable, at least transien...

Detailed Description

The measurement of circulating tumor cells is pursued in several cancers including breast and prostate cancer. The number of cells measured in these cancers has been shown to be prognostic. There is l...

Eligibility Criteria

Inclusion

  • Pathological diagnosis of transitional cell carcinoma of the urothelium of at least T2-4, Nx, Mx stage. Mixed histologies will be allowed (e.g. squamous differentiation) as long as a transitional cell component is present.
  • Clinical plans for surgery (with or without chemotherapy), radiation therapy, or chemotherapy.
  • Participants must not have any condition which in the investigator's opinion may compromise the feasibility of completing the study.
  • Subject must be 18 years of age or older
  • Subject must be willing to have up to 4 peripheral blood samples obtained over a 6 month period of study.
  • Prior therapies for bladder cancer will be allowed if patient currently has muscle-invasive or metastatic bladder cancer despite the previous treatments.
  • Predicted life expectancy of \> 12 weeks.

Exclusion

  • Subjects who are unwilling or unable to comply with the study guidelines as determined by the principal investigator.

Key Trial Info

Start Date :

November 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2013

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT00829920

Start Date

November 1 2008

End Date

February 1 2013

Last Update

June 25 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Colorado Hospital

Aurora, Colorado, United States, 80010